The costs of disease burden in Iran
Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health 2001; 22: 91-113.
Scallan E, Hoekstra RM, Mahon BE, Jones TF, Griffin PM. An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years. Epidemiol Infect 2015; 1-10.
Svihrova V, Svihra J, Luptak J, Swift S, Digesu GA. Disability-adjusted life years (DALYs) in general population with pelvic organ prolapse: a study based on the prolapse quality-of-life questionnaire (P-QOL). Eur J Obstet Gynecol Reprod Biol 2014; 182: 22-6.
Fox-Rushby J. Whose values count? A critique of disability adjusted life years (DALYs). Quality of Life Research 2001; 10(3): 27.
Aghazadeh R, Zali MR, Bahari A, Amin K,
Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 2005; 20(11): 1691-5.
Koiek S, Gharib A. Iran's healthcare system challenges at a glance. Chron Dis J 2013; 1(2): 96-7.
Vahabi B, Vahabi A, Gharib A, Sayyadi M, Sayyad S. Prevalence of head louse infestations and factors affecting the rate of infestation among primary schoolchildren in Paveh City, Kermanshah Province, Iran in the years 2009 to 2010. Life Sci J 2013; 10(12s): 360-4.
Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004; 291(21): 2616-22.
Razmi MJ, Abbasian E, Mohammadi S. Investigating the Effect of Government Health Expenditure on HDI in Iran. Journal of Knowledge Management, Economics and Information Technology 2012; (5).